Feb 18, 2025
13 Views
Comments Off on Premenstrual Syndrome Treatment Market Size, Growth, Share and Competitive Landscape – 2030
0 0

Premenstrual Syndrome Treatment Market Size, Growth, Share and Competitive Landscape – 2030

Written by

Global Premenstrual Syndrome Treatment Market Overview and Insights:

Premenstrual Syndrome Treatment Market research is an ongoing process. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

What is the Future Market Size of the Premenstrual Syndrome Treatment Industry and its Yearly Growth Rate?

The Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30. The demand for Premenstrual Syndrome (PMS) treatment solutions has been increasing consistently across the globe in recent years. This has been primarily influenced by the adoption of unhealthy lifestyles by a large population of women across the globe, mainly in regions such as North America and Europe. Globally, instances of PMS have been observed specifically across countries that have a high working female population. This is primarily because working women are generally unable to take care of their physical and mental well-being, owing to the time constraints, which have been leading to a hormonal imbalance among them. Consequently, the symptoms of PMS have been mainly observed among working women. Further, PMS often leads to mental issues like anxiety, depression, stress, etc., which reduces the work efficiency of women. Hence, to reduce the effect of PMS on their work schedule, most women opt for PMS treatment solutions, which have been responsible for the market growth & expansion in recent years.

Key Perks: “In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/premenstrual-syndrome-treatment-market.html

Who are the Main Competitors Driving the Global Premenstrual Syndrome Treatment Market Forward?

The prominent players essentially operating in the Premenstrual Syndrome Treatment Market are as follows:

  • Bayer AG
  • Pfizer Inc.
  • Zydus Cadila
  • Alkem Laboratories Ltd.
  • Kobayashi Pharmaceutical Co., Ltd.
  • Haleon Group of Companies
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Asarina Pharma AB
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd. (Accord Healthcare)
  • Ova Moon
  • AstraZeneca plc
  • Others

What are the key Drivers Defining the Global Premenstrual Syndrome Treatment Market Size?

Growing Instances of Premenstrual Dysphoric Disorder (PMDD) Driving Market Growth – Globally, the instances of PMDD emerged as one of the major market drivers, which has been growing significantly, which is in particular due to the growing fitness issues among women. PMDD is the greater extreme shape of premenstrual syndrome, which often results in excessive bodily abnormalities, like belly pain, weight pain, swelling of breasts, and so forth. Also, the predominant aspect besides PMDD is intense hormonal balance, which is frequently related to the genetics of women. Further, consistent stress and other neurological conditions may also affect the hormonal balance among women, leading to PMDD. Henceforth, as the instances of PMDD have been escalating, the demand for treatment solutions has also amplified, which has been driving the market growth. This demand is also expected to grow in the forecast years, as the instance of PMDD would increase further.

Full Market Research Report – https://www.marknteladvisors.com/research-library/premenstrual-syndrome-treatment-market.html

What is the Segmentation of the Global Premenstrual Syndrome Treatment Market?

The Premenstrual Syndrome Treatment market covered in this report is segmented –

  • By Drug Type
    • Analgesics- Market Size & Forecast 2019-2030, USD Million
    • Antidepressants- Market Size & Forecast 2019-2030, USD Million
    • Oral Contraceptives- Market Size & Forecast 2019-2030, USD Million
    • Ovarian Suppression Agents- Market Size & Forecast 2019-2030, USD Million
    • Others (Diuretics, Herbal Supplements, etc.)- Market Size & Forecast 2019-2030, USD Million

Out of them all, the oral contraceptives segment held a major market share. The market growth has been attributed to the occurrence of premenstrual syndrome among women of reproductive age.

  • By Type
    • Prescription- Market Size & Forecast 2019-2030, USD Million
    • Over-the-Counter (OTC)- Market Size & Forecast 2019-2030, USD Million
  • By Distribution Channel
    • Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
    • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
    • Online Pharmacies- Market Size & Forecast 2019-2030, USD Million)
  • By Region
    • North America
    • South America
    • Europe
    • The Middle East & Africa
    • Asia-Pacific

Key Questions Answered in the Research Report

  1. What is the predicted Premenstrual Syndrome Treatment market size and growth rate for the years 2024-30?
  2. What challenges are restricting the growth of the Premenstrual Syndrome Treatment market?
  3. Which segment accounted for the largest market share in the Premenstrual Syndrome Treatment market?
  4. Which prominent companies are leading growth in the Premenstrual Syndrome Treatment market?
  5. In what formats does Markntel Advisors deliver the concerned report descriptions?
  6. How long does it take for customers to receive the reports provided by Markntel Advisors?
  7. Does Markntel Advisors provide customized reports?

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.marknteladvisors.com/query/request-customization/premenstrual-syndrome-treatment-market.html

Read More:

For Further Queries:

Contact Us:  

MarkNtel Advisors

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Emailsales@marknteladvisors.com

Tel No: +1 628 895 8081, +91 120 4278433

Article Categories:
Business